hsk44459
Small moleculeexperimental
Clinical trial activity
7 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
6
Phase 3
0
Phase 4
0
Earliest trial started Aug 17, 2024 (NCT06858657)
Timeline
Indications
Mechanism of action
- Phosphodiesterase 4BINHIBITOR
PDE4B inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07150988 | Phase 2 | Sep 26, 2025 | Haisco Pharmaceutical |
| NCT07070739 | Phase 2 | Jul 31, 2025 | Haisco Pharmaceutical |
| NCT07019090 | Phase 2 | Jun 27, 2025 | Haisco Pharmaceutical |
| NCT06996912 | Phase 2 | May 26, 2025 | Haisco Pharmaceutical |
| NCT06902428 | Phase 2 | Mar 24, 2025 | Haisco Pharmaceutical |
| NCT06764862 | Phase 2 | Jan 27, 2025 | Haisco Pharmaceutical |
| NCT06858657 | Phase 1 | Aug 17, 2024 | Haisco Pharmaceutical |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Haisco Pharmaceutical | For profit | 7 | 7 | 2 | 2024 |
1 organizations
Page 1 / 1